See What HealthDay Can Do For You
Contact Us

Program Cuts Heart Risk Factors in Medically Underserved

'Heart Disease on the Mend' project reduces blood pressure, cholesterol levels and has high patient retention

FRIDAY, Dec. 8 (HealthDay News) -- A disease management program for low-income, medically underserved patients has been shown to lower cardiovascular risk factors and retain most study patients during a one-year follow-up, researchers report in the Dec. 1 issue of the American Journal of Cardiology.

William Haskell, Ph.D., of Stanford University in Stanford, Calif., evaluated a disease management approach to multifactorial cardiovascular disease risk reduction in low-income patients with limited or no health insurance. The "Heart Disease on the Mend" project included lifestyle guidance and medications delivered by nurses and dietitians, and supervised by a physician.

Patients randomized to the disease management program showed clinically relevant reductions in systolic blood pressure and low-density lipoprotein cholesterol during six and 12 month follow-ups, compared with usual care. The management program had a high rate of retention, with 91 percent of patients available at 12 months, and moved many "high-risk" and "very high-risk" patients to lower categories.

"The disease management program had excellent retention and lower cardiovascular disease risk factors and demonstrated the potential of such approaches for decreasing long-term disease burden in selected medically underserved populations," the authors conclude.

Pharmaceutical support was provided by Merck & Co.; Bristol-Myers Squibb Company; Kos Pharmaceuticals, Inc.; Abbott Laboratories; and SmithKline Beecham.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.